An exploratory study to investigate the effect of FE 999302 when given during different time periods to women undergoing controlled ovarian stimulation with follitropin delta
000427
Phase 1 other active
Quick answer
An exploratory study to investigate the effect of FE 999302 when given during different time periods to women undergoing controlled ovarian stimulation with follitropin delta for Infertility in women undergoing assisted reproductive technologies (ART) is a Phase 1 program (other) at Ferring Pharmaceuticals A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ferring Pharmaceuticals A/S
- Indication
- Infertility in women undergoing assisted reproductive technologies (ART)
- Phase
- Phase 1
- Modality
- other
- Status
- active